Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Radboud University |
---|---|
Information provided by: | Radboud University |
ClinicalTrials.gov Identifier: | NCT00306345 |
The identification of patients with potential early organ failure is the key in preventing admission or readmission to a critical care facility. The primary goal of the Outreach Project is to ensure that all patients with threatening organ failure receive appropriate and timely treatment in a suitable area; avoid admission to the intensive care unit (ICU); and share ICU skills by a partnership in education. The objectives of the study are to determine whether the introduction of an intensive care unit based medical emergency team, responding to hospital-wide preset criteria of physiologic instability, will decrease the number of predefined serious adverse events (SAEs) and to investigate the effects on quality of life and costs in a general surgery population.
Study Hypothesis: The Outreach intervention will decrease the number of predefined serious adverse events; increase quality of life; and decrease costs.
Condition | Intervention |
---|---|
Patient Centered Care Postoperative Care Critical Illness |
Behavioral: Outreach |
Study Type: | Observational |
Study Design: | Screening, Longitudinal, Defined Population, Prospective Study |
Official Title: | Outreach: A Programme for Early Recognition, Quick Response and Timely Treatment of Critically Ill Patients in a University Hospital |
Estimated Enrollment: | 1500 |
Study Start Date: | January 2006 |
Estimated Study Completion Date: | December 2008 |
DESIGN: A multi centre longitudinal intervention trial with a before and after design in a university hospital.
The INTERVENTION consists of three parts:
STUDY POPULATION: The population for this study consists of patients undergoing major general surgery with an admission stay of more than 48 hours. It includes patients undergoing central or peripheral vascular surgery, major oncological surgery, lung surgery, major abdominal surgery and trauma surgery.
MEASUREMENTS AND OUTCOMES: In total, 1500 patients will be included. (750 Patients in the control period and 750 patients in the intervention period). Measurements include the incidence of Serious Adverse Events, HRQoL (Quality of life EQ-5D), costs of care and ICU logistics.
TIME-SCHEDULE: Data collection starts January 1, 2006 and stops no later than three months after the inclusion of 1500 patients or April 1, 2008. The final report of the study will be in December 2008.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Gerrit Bloo, Master | 0031 24 3665011 | g.bloo@caiocb.umcn.nl |
Contact: Ton Haans, Master | 0031 24 3665012 | a.haans@ic.umcn.nl |
Netherlands, Gelderland | |
Radboud Universiteit Nijmegen Medical Center | Recruiting |
Nijmegen, Gelderland, Netherlands, 6500 HB | |
Contact: Gerrit Bloo, Master 0031 24 3665011 g.bloo@caiocb.umcn.nl | |
Contact: Ton Haans, Master 0031 24 3665012 a.haans@ic.umcn.nl | |
Principal Investigator: Hans van der Hoeven, Professor |
Principal Investigator: | Hans van der Hoeven, Professor | UMCN |
Study ID Numbers: | 001, CMO 301 |
Study First Received: | March 22, 2006 |
Last Updated: | July 11, 2007 |
ClinicalTrials.gov Identifier: | NCT00306345 |
Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Outreach Major general surgery Intensive care Serious adverse events |
Critical Illness |
Disease Attributes Pathologic Processes |